search
Back to results

Advanced eHealth for Chronic Obstructive Pulmonary Disease (COPD) in Colorado

Primary Purpose

Chronic Obstructive Pulmonary Disease

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Integrated Care
Standard Therapy
Sponsored by
University of Colorado, Denver
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Obstructive Pulmonary Disease focused on measuring Chronic obstructive pulmonary disease, telemedicine, COPD

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • COPD Diagnosis per GOLD Guidelines
  • Airflow obstruction on spirometry defined as an FEV1/FVC less than or equal to 70% and an FEV1 less than or equal to 50% predicted, or an FEV1 greater than 50% predicted with a history of a COPD exacerbation within the previous year.
  • Standard telephone access
  • US Citizen and Colorado resident

Exclusion Criteria:

  • Asthma
  • Co-existing conditions that are likely to cause death within two years, CXR evidence of interstitial lung disease or other pulmonary diagnoses at the time of enrollment, end-stage liver disease, end-stage renal disease, end-stage muscle disease, HIV disease or dementia.

Sites / Locations

  • University of Colorado Hospital
  • Kaiser Permanente

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Proactive Integrated Care

Standard Care Control

Arm Description

COPD-specific education, self-management instruction, remote monitoring and enhanced communication with a coordinator

No intervention other that measurements taken at 0, 3, 6 and 9 months of the study.

Outcomes

Primary Outcome Measures

Healthcare utilization

Secondary Outcome Measures

Quality of Life by St. Georges Respiratory Questionnaire
Guideline-based medical therapy
Exercise capacity
Oxygen utilization and pre-and post-exercise oxygen saturations
Body Mass Index, Obstruction, Dyspnoea, Exercise Capacity (BODE) index
Symptoms including cough, sputum production and dyspnea (modified Medical Research Council (MMRC) MMRC Dyspnea Scale)
Smoking status
Pulmonary rehabilitation

Full Information

First Posted
January 6, 2010
Last Updated
October 3, 2012
Sponsor
University of Colorado, Denver
Collaborators
Colorado Department of Public Health and Environment, Kaiser Permanente, US Department of Veterans Affairs
search

1. Study Identification

Unique Protocol Identification Number
NCT01044927
Brief Title
Advanced eHealth for Chronic Obstructive Pulmonary Disease (COPD) in Colorado
Official Title
Phase 3 Clinical Trial Studying the Efficacy of a Proactive Integrated Approach to Care in Patients With Advanced COPD
Study Type
Interventional

2. Study Status

Record Verification Date
October 2012
Overall Recruitment Status
Completed
Study Start Date
September 2006 (undefined)
Primary Completion Date
August 2007 (Actual)
Study Completion Date
June 2008 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Colorado, Denver
Collaborators
Colorado Department of Public Health and Environment, Kaiser Permanente, US Department of Veterans Affairs

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Chronic obstructive pulmonary disease (COPD) is the 4th leading cause of death in the United States, affects 24 million people and is responsible for up to $32 billion annually in direct and indirect health care costs. Based upon these national COPD prevalence data, we estimate that 483,000 Coloradans have COPD (193,000 diagnosed and 290,000 undiagnosed), and that the care of these patients costs up to $490 million annually. Therefore, to alter the impact of COPD on the State and People of Colorado, we propose to introduce a telephone-dependent, internet-supported, self-monitoring "eHealth" management system in both urban and rural Colorado settings in order to decrease healthcare utilization, improve the management of COPD based upon current national guidelines, improve quality of life, reduce health care costs decrease COPD exacerbations. We base this program on a successful clinical pilot study, performed at the University of Colorado Hospital (UCH) during 2004-2005, which demonstrated dramatic improvements in quality of life and decreased health care costs. We propose to enroll patients with advanced COPD, or a history of COPD exacerbations, because these are the patients with the highest healthcare costs, the greatest disability, and the highest mortality. The ultimate goal of this project is to demonstrate the feasibility and efficacy of this proactive management strategy as it is disseminated throughout urban and rural Colorado. In this first phase we will target two Denver Metro sites, UCH and Kaiser-Permanente (KP), and rural sites (to be determined). We chose these urban sites because of their strong interest in enacting the eHealth Program, because of their organized systems of healthcare delivery and because of the numbers of COPD patients that they serve. We are particularly enthusiastic about the application of this technology to rural, underserved areas, because this approach has the potential to dramatically improve delivery of healthcare to a large portion of Colorado that is chronically plagued by inadequate health care networks and lack of specialty care. More broadly, we are enthusiastic about the prospect that eHealth programs may hold the potential to improve healthcare delivery for many chronic illnesses, in addition to COPD.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease
Keywords
Chronic obstructive pulmonary disease, telemedicine, COPD

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
511 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Proactive Integrated Care
Arm Type
Experimental
Arm Description
COPD-specific education, self-management instruction, remote monitoring and enhanced communication with a coordinator
Arm Title
Standard Care Control
Arm Type
Active Comparator
Arm Description
No intervention other that measurements taken at 0, 3, 6 and 9 months of the study.
Intervention Type
Other
Intervention Name(s)
Integrated Care
Intervention Description
Comparison of the effect of COPD education, self-management instruction, home monitoring with a Health Buddy Telemonitor, pulse oximeter, pedometer and spirometer, and enhanced communication with a study coordinator (cell phone access)
Intervention Type
Other
Intervention Name(s)
Standard Therapy
Intervention Description
No intervention was made. Data measurements were taken at 0, 3, 6 and 9 months, as in the active intervention group.
Primary Outcome Measure Information:
Title
Healthcare utilization
Time Frame
9 months
Secondary Outcome Measure Information:
Title
Quality of Life by St. Georges Respiratory Questionnaire
Time Frame
3, 6 and 9 months
Title
Guideline-based medical therapy
Time Frame
9 months
Title
Exercise capacity
Time Frame
9 months
Title
Oxygen utilization and pre-and post-exercise oxygen saturations
Time Frame
9 months
Title
Body Mass Index, Obstruction, Dyspnoea, Exercise Capacity (BODE) index
Time Frame
9 months
Title
Symptoms including cough, sputum production and dyspnea (modified Medical Research Council (MMRC) MMRC Dyspnea Scale)
Time Frame
9 months
Title
Smoking status
Time Frame
9 months
Title
Pulmonary rehabilitation
Time Frame
9 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: COPD Diagnosis per GOLD Guidelines Airflow obstruction on spirometry defined as an FEV1/FVC less than or equal to 70% and an FEV1 less than or equal to 50% predicted, or an FEV1 greater than 50% predicted with a history of a COPD exacerbation within the previous year. Standard telephone access US Citizen and Colorado resident Exclusion Criteria: Asthma Co-existing conditions that are likely to cause death within two years, CXR evidence of interstitial lung disease or other pulmonary diagnoses at the time of enrollment, end-stage liver disease, end-stage renal disease, end-stage muscle disease, HIV disease or dementia.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William Vandivier, MD
Organizational Affiliation
University of Colorado, Denver
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Colorado Hospital
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
Facility Name
Kaiser Permanente
City
Denver
State/Province
Colorado
ZIP/Postal Code
80218
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Advanced eHealth for Chronic Obstructive Pulmonary Disease (COPD) in Colorado

We'll reach out to this number within 24 hrs